Wednesday, February 1, 2023
  • Login
The Science Serve
  • Home
  • Healthcare
  • Technology
  • Market
  • Contact Us
  • More
    • Privacy Policy
    • Disclaimer
    • Editorial Policy and Guidelines
    • Terms and Conditions
No Result
View All Result
The Science Serve
No Result
View All Result
Home Market

MARKET INSIGHTS ON FUTURE OF IMMUNOTHERAPY

Vidhi Punamiya by Vidhi Punamiya
March 21, 2020
in Market
Reading Time: 3 mins read
0 0
A A
0
MARKET INSIGHTS ON FUTURE OF IMMUNOTHERAPY
Share on FacebookShare on Twitter

The cancer immunotherapy market is expected to grow at a Compounded Annual Growth Rate (CAGR) of 10.2% in the coming 6 years and will reach a market valuation worth US$ 115.4 Billion. This growth can be directly projected to increasing cancer incidence all around the world. Hence to counter this ever-increasing number, it is projected that more resources will go into R&D activities which will aim to increase the effectiveness of cancer diagnosis mechanisms and treatment therapies.

This industry is overly competitive in the current times. But in the coming years, it is projected that this competition is about to soar high with each passing day. The predominant participants in this industry include several big and small names like Amgen Inc., AstraZeneca, Bayer AG, Bristol-Myers Squibb, Eli Lilly and Co, F. Hoffman, La Roche, Merck and Co, Novartis, and Pfizer.

The major parameters affecting the competitiveness of these ventures are as follows:

  • The sector is rapidly adopting upgraded treatment mechanisms for optimal healthcare measures
  • The sector is also deeply affected by the rising need for optimum utilization of capital and other resources.
  • Additionally, to diversify the product portfolio and retain their shares, these big players are taking mergers and acquisitions as a way out to thrive in this scenario

Key immunotherapy industry trends to be looking out for in the coming future

New, less toxic treatments are emerging, but chemotherapies for cancer treatments are not disappearing anytime soon.

Obviously with the new and better treatments coming in, the pertinent question becomes: Is chemotherapy on its way out? Experts say that though its days are numbered but this is not happening anytime soon. One of the main reasons is that chemotherapy for some kind of cancers are very effective and even curative. Worldwide, a total of 57.7% of cancer cases required chemotherapy which accounts for 9.8 million cases out of 17 million cancer cases in 2018. It is also said that by 2040, the number of cancer cases will rise by 26 million and out of that 53% are expected to be treated by chemotherapy.

Monoclonal antibodies will keep dominating the cancer immunotherapy market

Monoclonal antibodies were quite dominant in the sector in 2018, as dominant as that they took up a 27% share in the global immunotherapy market. In the coming times, it is expected that 60% of previously treated cancer patients will opt for immunology. We are likely to see more advancement in the same field of therapy treatments being adopted for cancer treatments. Cancer cases are expected to be cured by immunotherapy where the patient’s own immune system will be used to fight off these diseases unlike the current medical treatments like radiotherapy, chemotherapy or surgery. But the rising effectiveness of immunomodulatory drugs is becoming the main reason for it to gain deep market penetration in shorter durations. While thorough research is going on these approved drugs, these market giants are also full-fledged working towards introducing novel therapies.

Key takeaways

  • In the cancer therapeutic space, immunotherapeutic drugs have gained worldwide acceptance which paves the way for further mind-boggling developments in the field.
  • To date, cancer immunotherapy drugs have a market standing of over and above 50 percent of the overall oncology medicine market and are worth $100 billion globally
  • Taking this further, stronger and higher growth rates are expected in the future pertaining to increasing trends of hematological cancers.
Post Views: 139
Tags: Featuredmarket
Vidhi Punamiya

Vidhi Punamiya

Vidhi is a full-time freelancer pursuing her passion in content writing. She has handled quite a few projects spanning over various industries from travel to technology.

POPULAR NEWS

  • Why are Men Taller than Women?

    Why are Men Taller than Women?

    0 shares
    Share 0 Tweet 0
  • DENTIST IN SPACE: UPCOMING ERA OF AEROSPACE DENTISTRY

    0 shares
    Share 0 Tweet 0
  • Development and Applications of electronic skin

    0 shares
    Share 0 Tweet 0
  • Discovery of World’s First Animal that Can Survive Without Oxygen

    0 shares
    Share 0 Tweet 0
  • Covid-19: Don’t DIY your immunity

    0 shares
    Share 0 Tweet 0
The Science Serve

We bring you the best Premium WordPress Themes that perfect for news, magazine, personal blog, etc.

Follow us on social media:

Recent News

  • Can memories be transferred?
  • Early life stress and Epigenetics of Depression
  • The first step towards genetic medicine for Transthyretin Amyloidosis

Category

  • Diagnosis
  • Featured
  • Health
  • Healthcare
  • Insights
  • Lifestyle
  • Market
  • Opinion
  • Science
  • Talk
  • Technology
  • Uncategorized

Recent News

Can memories be transferred?

Can memories be transferred?

December 13, 2022
Early life stress and Epigenetics of Depression

Early life stress and Epigenetics of Depression

October 21, 2022

© 2021 Thescienceserve

No Result
View All Result
  • Home
  • Healthcare
  • Technology
  • Market
  • Contact Us
  • More
    • Privacy Policy
    • Disclaimer
    • Editorial Policy and Guidelines
    • Terms and Conditions

© 2021 Thescienceserve

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?